LPL Financial
AVXL icon

LPL Financial’s Anavex Life Sciences AVXL Stock Holding History

LPL Financial’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
406,109
-12,531
-3% -$37.1K ﹤0.01% 4378
2026
Q1 		$1.29M Sell
418,640
-110,142
-21% -$477K ﹤0.01% 3935
2025
Q4 		$1.88M Sell
528,782
-5,537
-1% -$33.9K ﹤0.01% 3476
2025
Q3 		$4.76M Sell
534,319
-24,023
-4% -$244K ﹤0.01% 2511
2025
Q2 		$5.15M Buy
558,342
+11,716
+2% +$100K ﹤0.01% 2283
2025
Q1 		$4.69M Buy
546,626
+452,723
+482% +$4.27M ﹤0.01% 2202
2024
Q4 		$1.01M Buy
93,903
+25,048
+36% +$193K ﹤0.01% 3482
2024
Q3 		$391K Buy
68,855
+15,550
+29% +$89.7K ﹤0.01% 4216
2024
Q2 		$225K Sell
53,305
-5,775
-10% -$23.4K ﹤0.01% 4478
2024
Q1 		$301K Buy
59,080
+200
+0.3% +$1.13K ﹤0.01% 4196
2023
Q4 		$548K Buy
58,880
+2,940
+5% +$20.2K ﹤0.01% 3587
2023
Q3 		$366K Sell
55,940
-4,965
-8% -$39.5K ﹤0.01% 3741
2023
Q2 		$495K Buy
60,905
+11,740
+24% +$101K ﹤0.01% 3456
2023
Q1 		$421K Buy
49,165
+5,525
+13% +$55.1K ﹤0.01% 3474
2022
Q4 		$404K Buy
43,640
+3,800
+10% +$40.6K ﹤0.01% 3437
2022
Q3 		$411K Buy
39,840
+2,410
+6% +$25.4K ﹤0.01% 3326
2022
Q2 		$375K Buy
37,430
+11,185
+43% +$106K ﹤0.01% 3444
2022
Q1 		$323K Buy
26,245
+10,250
+64% +$126K ﹤0.01% 3524
2021
Q4 		$277K Sell
15,995
-4,693
-23% -$89.2K ﹤0.01% 3736
2021
Q3 		$371K Buy
20,688
+8,913
+76% +$177K ﹤0.01% 3475
2021
Q2 		$269K Buy
+11,775
New +$174K ﹤0.01% 3670

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial's AVXL Position: Q2 2026 in Review

LPL Financial reduced its Anavex Life Sciences (AVXL) stake by 3% in Q2 2026, selling an estimated $37.1K and leaving 406,109 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #4378.

LPL Financial first reported a position in AVXL in Q2 2021 and has held it in 21 quarters since. The position peaked at $5.15M in Q2 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • LPL Financial held 406,109 shares of Anavex Life Sciences worth $1.05M as of Q2 2026.
  • LPL Financial sold 12,531 Anavex Life Sciences shares in Q2 2026, an estimated $37.1K.
  • Anavex Life Sciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4378 holding.
  • LPL Financial first reported a position in Anavex Life Sciences in Q2 2021 and has held it in 21 quarters since.
  • LPL Financial's Anavex Life Sciences position peaked at $5.15M in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.